The role of IL10 in LES is controversial, it has been considered as an anti-inflammatory mediator, but some studies demonstrate that the administration of IL10 accelerates the onset of renal disease, high serum levels of IL10 are found in patients with SLE and correlates with the disease activity [33]–[35]. The gene discussed is IL10; the disease is systemic lupus erythematosus.